Articles

Activity of everolimus (RAD001) in relapsed and/or refractory multiple myeloma: a phase I study

Division of Stem Cell Transplantation and Immunotherapy, 2nd Department of Medicine, University of Kiel, Germany
Medizinische Klinik und Poliklinik IV, Klinikum der Ludwig-Maximillians-Universität München (LMU), Germany
Division of Stem Cell Transplantation and Immunotherapy, 2nd Department of Medicine, University of Kiel, Germany
Division of Stem Cell Transplantation and Immunotherapy, 2nd Department of Medicine, University of Kiel, Germany
Division of Hematopathology, Institute of Pathology, University of Kiel, Germany
Medizinische Klinik und Poliklinik IV, Klinikum der Ludwig-Maximillians-Universität München (LMU), Germany
Division of Stem Cell Transplantation and Immunotherapy, 2nd Department of Medicine, University of Kiel, Germany
Vol. 100 No. 4 (2015): April, 2015 https://doi.org/10.3324/haematol.2014.116269